Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells

References

• Ahmad FB, Cisewski JA, Xu J, et al. Provisional Mortality Data — United States, 2022. MMWR Morb. Mortal. Wkly. Rep. 2023;72(18):488–492. doi: 10.15585/mmwr.mm7218a3
   PubMedGoogle Scholar
• Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021 Apr 7;42(14):1289–1367.
   PubMed Web of Science ®Google Scholar
• Ibanez B, James S, Agewall S, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017;39(2):119–177.
   Web of Science ®Google Scholar
• Alraies MC, Eckman P. Adult heart transplant: indications and outcomes. J Thorac Dis. 2014 Aug;6(8):1120–1128. doi: 10.3978/j.issn.2072-1439.2014.06.44
   PubMed Web of Science ®Google Scholar
• Niccoli G, Burzotta F, Galiuto L, et al. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009 Jul 21;54(4):281–292.
   PubMed Web of Science ®Google Scholar
• Przybyt E, Harmsen MC. Mesenchymal stem cells: promising for myocardial regeneration? Curr Stem Cell Res Ther. 2013 Jul;8(4):270–277. doi: 10.2174/1574888X11308040002
   PubMed Web of Science ®Google Scholar
• Lalu MM, Mazzarello S, Zlepnig J, et al. Safety and efficacy of adult stem cell therapy for acute myocardial infarction and ischemic heart failure (safecell heart): a systematic review and meta-analysis. Stem Cells Transl Med. 2018 Dec;7(12):857–866. doi: 10.1002/sctm.18-0120
   PubMed Web of Science ®Google Scholar
• Wu K Hong, Mo X Ming, Han Z Chao and Zhou B. (2011). Stem Cell Engraftment and Survival in the Ischemic Heart. The Annals of Thoracic Surgery, 92(5), 1917–1925. doi: 10.1016/j.athoracsur.2011.07.012
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618–e651. doi: 10.1161/CIR.0000000000000617
   PubMed Web of Science ®Google Scholar
• Anderson JL, Morrow DA, Campion EW. Acute myocardial infarction. N Engl J Med. 2017 May 25;376(21):2053–2064.
   PubMed Web of Science ®Google Scholar
• Broughton KM, Wang BJ, Firouzi F, et al. Mechanisms of cardiac repair and regeneration. Circ Res. 2018;122(8):1151–1163. doi: 10.1161/CIRCRESAHA.117.312586
   PubMed Web of Science ®Google Scholar
• Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016 Jun 24;119(1):91–112.
   PubMed Web of Science ®Google Scholar
• Katrukha IA, Katrukha AG. Myocardial injury and the release of troponins I and T in the blood of patients. Clin Chem. 2020;67(1):124–130. doi: 10.1093/clinchem/hvaa281
   Web of Science ®Google Scholar
• Arora S, Stouffer GA, Kucharska-Newton A, et al. Fifteen-year trends in management and outcomes of non-ST-segment-elevation myocardial infarction among black and white patients: the ARIC community surveillance study, 2000-2014. J Am Heart Assoc. 2018 Oct 2;7(19):e010203.
   PubMed Web of Science ®Google Scholar
• Ghafoor M, Kamal M, Nadeem U and Husain A N. (2020). Educational Case: Myocardial Infarction: Histopathology and Timing of Changes. Academic Pathology, 7 2374289520976639. doi: 10.1177/2374289520976639
   Web of Science ®Google Scholar
• DeFilippis AP, Hall ME. Impact of new ICD codes on acute MI characteristics and outcomes. J Am Coll Cardiol. 2021;78(12):1254–1256. doi: 10.1016/j.jacc.2021.07.033
   PubMed Web of Science ®Google Scholar
• Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009 Apr 3;324(5923):98–102.
   PubMed Web of Science ®Google Scholar
• Fernández-Avilés F, Sanz-Ruiz R, Climent AM, et al. Global position paper on cardiovascular regenerative medicine. Eur Heart J. 2017 Sep 1;38(33):2532–2546.
   PubMed Web of Science ®Google Scholar
• Iseoka H, Miyagawa S, Saito A, et al. Role and therapeutic effects of skeletal muscle-derived non-myogenic cells in a rat myocardial infarction model. Stem Cell Res Ther. 2020 Feb 18;11(1):69.
   PubMed Web of Science ®Google Scholar
• Schächinger V, Erbs S, Elsässer A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006 Sep 21;355(12):1210–1221.
   PubMed Web of Science ®Google Scholar
• Prat-Vidal C, Crisóstomo V, Moscoso I, et al. Intracoronary delivery of porcine cardiac progenitor cells overexpressing IGF-1 and HGF in a pig model of sub-acute myocardial infarction. Cells. 2021;10(10):2571. doi: 10.3390/cells10102571
   PubMed Web of Science ®Google Scholar
• Tokunaga M, Liu M-L, Nagai T, et al. Implantation of cardiac progenitor cells using self-assembling peptide improves cardiac function after myocardial infarction. J Mol Cell Cardiol. 2010 Dec 01;49(6):972–983.
   PubMed Web of Science ®Google Scholar
• Malliaras K, Makkar RR, Smith RR, et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (cardiosphere-derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol. 2014 Jan 21;63(2):110–122.
   PubMed Web of Science ®Google Scholar
• Chong JJ, Yang X, Don CW, et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature. 2014 Jun 12;510(7504):273–277.
   PubMed Web of Science ®Google Scholar
• Thavapalachandran S, TYL L, Romanazzo S, et al. Pluripotent stem cell-derived mesenchymal stromal cells improve cardiac function and vascularity after myocardial infarction. Cytotherapy. 2021 Dec;23(12):1074–1084. doi: 10.1016/j.jcyt.2021.07.016
   PubMed Web of Science ®Google Scholar
• Menasché P. Skeletal myoblasts and cardiac repair. J Mol Cell Cardiol. 2008 Oct 01;45(4):545–553.
   PubMed Web of Science ®Google Scholar
• Scorsin M, Hagège A, Vilquin JT, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg. 2000 Jun;119(6):1169–1175. doi: 10.1067/mtc.2000.104865
   PubMed Web of Science ®Google Scholar
• Menasché P, Alfieri O, Janssens S, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation. 2008 Mar 4;117(9):1189–1200.
   PubMed Web of Science ®Google Scholar
• Eaves CJ. Hematopoietic stem cells: concepts, definitions, and the new reality. Blood. 2015 Apr 23;125(17):2605–2613.
   PubMed Web of Science ®Google Scholar
• Huizer K, Mustafa DA, Spelt JC, et al. Improving the characterization of endothelial progenitor cell subsets by an optimized FACS protocol. PLoS ONE. 2017;12(9):e0184895 10.1371. doi: 10.1371/journal.pone.0184895.
   PubMed Web of Science ®Google Scholar
• Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002 Oct 8;106(15):1913–1918.
   PubMed Web of Science ®Google Scholar
• Cao F, Sun D, Li C, et al. Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. Eur Heart J. 2009 Aug;30(16):1986–1994. doi: 10.1093/eurheartj/ehp220
   PubMed Web of Science ®Google Scholar
• Traverse JH, Henry TD, Ellis SG, et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA. 2011 Nov 16;306(19):2110–2119.
   PubMed Web of Science ®Google Scholar
• Traverse JH, Henry TD, Pepine CJ, et al. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA. 2012 Dec 12;308(22):2380–2389.
   PubMed Web of Science ®Google Scholar
• Choudry F, Hamshere S, Saunders N, et al. A randomized double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial†. Eur Heart J. 2016 Jan 14;37(3):256–263.
   PubMed Web of Science ®Google Scholar
• Mathur A, Fernández-Avilés F, Bartunek J, et al. The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial. Eur Heart J. 2020;41(38):3702–3710. doi: 10.1093/eurheartj/ehaa651
   PubMed Web of Science ®Google Scholar
• Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell And Tissue Kinetics. 1970 Oct;3(4):393–403. doi: 10.1111/j.1365-2184.1970.tb00347.x
   PubMedGoogle Scholar
• Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002 Dec;13(12):4279–4295. doi: 10.1091/mbc.e02-02-0105
   PubMed Web of Science ®Google Scholar
• Haynesworth SE, Goshima J, Goldberg VM, et al. Characterization of cells with osteogenic potential from human marrow. Bone. 1992;13(1):81–88. doi: 10.1016/8756-3282(92)90364-3
   PubMed Web of Science ®Google Scholar
• Girdlestone J, Limbani VA, Cutler AJ, et al. Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions. Cytotherapy. 2009;11(6):738–748. doi: 10.3109/14653240903079401
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. Cytotherapy. 2006;8(4):315–317. doi: 10.1080/14653240600855905
   PubMed Web of Science ®Google Scholar
• Zuk PA, Zhu M, Mizuno H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211–228. doi: 10.1089/107632701300062859
   PubMedGoogle Scholar
• Planat-Benard V, Silvestre JS, Cousin B, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004 Feb 10;109(5):656–663.
   PubMed Web of Science ®Google Scholar
• Karaöz E, Çetinalp Demircan P, Erman G, et al. Comparative analyses of immunosuppressive characteristics of bone-marrow, wharton’s jelly, and adipose tissue-derived human mesenchymal stem cells. Turk J Haematol. 2017 Aug 2;34(3):213–225.
   PubMed Web of Science ®Google Scholar
• Hare JM, Traverse JH, Henry TD, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009 Dec 8;54(24):2277–2286.
   PubMed Web of Science ®Google Scholar
• Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7634–7638. doi: 10.1073/pnas.78.12.7634
   PubMed Web of Science ®Google Scholar
• Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998 Nov 6;282(5391):1145–1147.
   PubMed Web of Science ®Google Scholar
• Hartman ME, Dai DF, Laflamme MA. Human pluripotent stem cells: prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Adv Drug Deliv Rev. 2016 Jan 15;96:3–17. doi: 10.1016/j.addr.2015.05.004.
   PubMed Web of Science ®Google Scholar
• Liu YW, Chen B, Yang X, et al. Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates. Nat Biotechnol. 2018 Aug;36(7):597–605. doi: 10.1038/nbt.4162
   PubMed Web of Science ®Google Scholar
• Robertson JA. Human embryonic stem cell research: ethical and legal issues. Nat Rev Genet. 2001 Jan 01;2(1):74–78.
   PubMed Web of Science ®Google Scholar
• Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell. 2007 Jun 7;1(1):39–49.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–872. doi: 10.1016/j.cell.2007.11.019
   PubMed Web of Science ®Google Scholar
• Lee J-H, Lee JB, Shapovalova Z, et al. Somatic transcriptome priming gates lineage-specific differentiation potential of human-induced pluripotent stem cell states. Nat Commun. 2014 Dec 03;5(1):5605.
   PubMedGoogle Scholar
• Nelson TJ, Martinez-Fernandez A, Yamada S, et al. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation. 2009;120(5):408–416. doi: 10.1161/CIRCULATIONAHA.109.865154
   PubMed Web of Science ®Google Scholar
• Batalov I, Feinberg AW. Differentiation of cardiomyocytes from human pluripotent stem cells using monolayer culture. Biomark Insights. 2015;10(Suppl 1):71–76. doi: 10.4137/BMI.S20050
   PubMedGoogle Scholar
• VV O, FE VDH, Petrus-Reurer S, et al. Generation, expansion and functional analysis of endothelial cells and pericytes derived from human pluripotent stem cells. Nat Protoc. 2014;9(6):1514–1531. doi: 10.1038/nprot.2014.102
   PubMed Web of Science ®Google Scholar
• Xie CQ, Huang H, Wei S, et al. A comparison of murine smooth muscle cells generated from embryonic versus induced pluripotent stem cells. Stem Cells Dev. 2009 Jun;18(5):741–748. doi: 10.1089/scd.2008.0179
   PubMed Web of Science ®Google Scholar
• Mauritz C, Schwanke K, Reppel M, et al. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation. 2008 Jul 29;118(5):507–517.
   PubMed Web of Science ®Google Scholar
• Garbern JC and Lee RT. Mitochondria and metabolic transitions in cardiomyocytes: lessons from development for stem cell-derived cardiomyocytes. Stem Cell Res Ther. 2021;12(1). doi: 10.1186/s13287-021-02252-6
   PubMed Web of Science ®Google Scholar
• Karbassi E, Fenix A, Marchiano S, et al. Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine. Nat Rev Cardiol. 2020 Jun;17(6):341–359. doi: 10.1038/s41569-019-0331-x
   PubMed Web of Science ®Google Scholar
• Machiraju P, Greenway SC. Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes. World J Stem Cells. 2019 Jan 26;11(1):33–43.
   PubMed Web of Science ®Google Scholar
• Scuderi GJ, Butcher J. Naturally engineered maturation of cardiomyocytes. Front Cell Dev Biol. 2017;5:50. doi: 10.3389/fcell.2017.00050
   PubMed Web of Science ®Google Scholar
• Kaneko S, Yamanaka S. To be immunogenic, or not to be: that’s the iPSC question. Cell Stem Cell. 2013 Apr 4;12(4):385–386.
   PubMed Web of Science ®Google Scholar
• Qiao Y, Agboola OS, Hu X, et al. Tumorigenic and immunogenic properties of induced pluripotent stem cells: a promising cancer vaccine. Stem Cell Rev And Rep. 2020 Dec;16(6):1049–1061. doi: 10.1007/s12015-020-10042-5
   PubMed Web of Science ®Google Scholar
• Tu C, Zoldan J. Moving Ipsc-derived cardiomyocytes forward to treat myocardial infarction. Cell Stem Cell. 2018 Sep 6;23(3):322–323.
   PubMed Web of Science ®Google Scholar
• Mazo M, Araña M, Pelacho B, et al. Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap. Stem Cells Int. 2012 Jan 22;2012:175979.
   PubMed Web of Science ®Google Scholar
• Hafez P, Jose S, Chowdhury SR, et al. Cardiomyogenic differentiation of human sternal bone marrow mesenchymal stem cells using a combination of basic fibroblast growth factor and hydrocortisone. Cell Biol Int. 2016;40(1):55–64. doi: 10.1002/cbin.10536
   PubMed Web of Science ®Google Scholar
• Raman N, Imran SAM, Ahmad Amin Noordin KB, et al. Mechanotransduction of mesenchymal stem cells (MSCs) during cardiomyocytes differentiation. Heliyon. 2022 Nov 01;8(11):e11624.
   PubMed Web of Science ®Google Scholar
• Martin-Rendon E, Sweeney D, Lu F, et al. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang. 2008 Aug;95(2):137–148. doi: 10.1111/j.1423-0410.2008.01076.x
   PubMed Web of Science ®Google Scholar
• Quevedo HC, Hatzistergos KE, Oskouei BN, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A. 2009;106(33):14022–14027. doi: 10.1073/pnas.0903201106
   PubMed Web of Science ®Google Scholar
• Leri A, Rota M, Hosoda T, et al. Cardiac stem cell niches. Stem Cell Res. 2014 Nov;13(3 Pt B):631–646. doi: 10.1016/j.scr.2014.09.001
   PubMed Web of Science ®Google Scholar
• Pokrovskaya LA, Zubareva EV, Nadezhdin SV, et al. Biological activity of mesenchymal stem cells secretome as a basis for cell-free therapeutic approach. Res Results Pharmacol. 2020;6(1):57–68. doi: 10.3897/rrpharmacology.6.49413
   Google Scholar
• Gnecchi M, He H, Noiseux N, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006 Apr;20(6):661–669. doi: 10.1096/fj.05-5211com
   PubMed Web of Science ®Google Scholar
• Nikoloff J M, Saucedo-Espinosa M A, Kling A and Dittrich P S. (2021). Identifying extracellular vesicle populations from single cells. Proc. Natl. Acad. Sci. U.S.A., 118(38). doi: 10.1073/pnas.2106630118
   PubMed Web of Science ®Google Scholar
• Teixeira FG, Salgado AJ. Mesenchymal stem cells secretome: current trends and future challenges. Neural Regen Res. 2020 Jan;15(1):75–77. doi: 10.4103/1673-5374.264455
   PubMed Web of Science ®Google Scholar
• Kishore R, Garikipati VNS, Gumpert A. Tiny shuttles for information transfer: exosomes in cardiac health and disease. J Cardiovasc Transl Res. 2016 Jun;9(3):169–175. doi: 10.1007/s12265-016-9682-4
   PubMed Web of Science ®Google Scholar
• Taheri B, Soleimani M, Fekri Aval S, et al. Induced pluripotent stem cell-derived extracellular vesicles: A novel approach for cell-free regenerative medicine. J Cell Physiol. 2019 Jun;234(6):8455–8464. doi: 10.1002/jcp.27775
   PubMed Web of Science ®Google Scholar
• HR M, Bayraktar E, KH G, et al. Exosomes: from garbage bins to promising therapeutic targets. Int J Mol Sci. 2017 Mar 2;18(3):538.
   PubMed Web of Science ®Google Scholar
• Gentek R, Hoeffel G. The innate immune response in myocardial infarction, repair, and regeneration. Adv Exp Med Biol. 2017;1003:251–272.
   PubMed Web of Science ®Google Scholar
• van den Akker F, de Jager SCA, Sluijter JPG, et al. Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors. Mediators Inflamm. 2013 Dec 10;2013:1–13. doi: 10.1155/2013/181020.
   Web of Science ®Google Scholar
• Ruparelia N, Chai JT, Fisher EA, et al. Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nat Rev Cardiol. 2017 Mar;14(3):133–144. doi: 10.1038/nrcardio.2016.185
   PubMed Web of Science ®Google Scholar
• Williams A R, Hare J M, and . (2011). Mesenchymal Stem Cells. Circ Res, 109(8), 923–940. doi: 10.1161/CIRCRESAHA.111.243147
   PubMed Web of Science ®Google Scholar
• Hare J M et al . (2012). Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy. JAMA, 308(22), 2369. doi: 10.1001/jama.2012.25321
   PubMed Web of Science ®Google Scholar
• Hare J M et al . (2017). Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy. Journal of the American College of Cardiology, 69(5), 526–537. doi: 10.1016/j.jacc.2016.11.009
   PubMed Web of Science ®Google Scholar
• Golpanian S, Wolf A, Hatzistergos KE, et al. Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiol Rev. 2016 Jul;96(3):1127–1168. doi: 10.1152/physrev.00019.2015
   PubMed Web of Science ®Google Scholar
• Sun YQ, Zhang Y, Li X, et al. Insensitivity of human iPS cells-derived mesenchymal stem cells to interferon-γ-induced hla expression potentiates repair efficiency of hind limb ischemia in immune humanized NOD scid gamma mice. Stem Cells. 2015 Dec;33(12):3452–3467. doi: 10.1002/stem.2094
   PubMed Web of Science ®Google Scholar
• Haworth R, Sharpe M. Accept or reject: the role of immune tolerance in the development of stem cell therapies and possible future approaches. Toxicol Pathol. 2021;49(7):1308–1316. doi: 10.1177/0192623320918241.
   PubMed Web of Science ®Google Scholar
• Li N, Hua J. Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci. 2017 Jul;74(13):2345–2360. doi: 10.1007/s00018-017-2473-5
   PubMed Web of Science ®Google Scholar
• Dittrich A, Lauridsen H. Myocardial infarction and the immune response - Scarring or regeneration? A comparative look at mammals and popular regenerating animal models. J Immunol Reg Med. 2019 Jun 01;4:100016. doi: 10.1016/j.regen.2019.100016.
   Google Scholar
• Guo J, Lin GS, Bao CY, et al. Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction. Inflammation. 2007 Aug;30(3–4):97–104. doi: 10.1007/s10753-007-9025-3
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen X, Cao W, et al. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol. 2014 Nov;15(11):1009–1016. doi: 10.1038/ni.3002
   PubMed Web of Science ®Google Scholar
• Ren G, Zhang L, Zhao X, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008 Feb 7;2(2):141–150.
   PubMed Web of Science ®Google Scholar
• Yan X, Anzai A, Katsumata Y, et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol. 2013 Sep;62:24–35.
   PubMed Web of Science ®Google Scholar
• Duncan SE, Gao S, Sarhene M, et al. Macrophage activities in myocardial infarction and heart failure. Cardiol Res Pract. 2020;2020:4375127. doi: 10.1155/2020/4375127
   PubMed Web of Science ®Google Scholar
• Lantz C, Becker A and Thorp E B. (2021). Can polarization of macrophage metabolism enhance cardiac regeneration?. Journal of Molecular and Cellular Cardiology, 160 87–96. doi: 10.1016/j.yjmcc.2021.07.003
   PubMed Web of Science ®Google Scholar
• Chiossone L, Conte R, Spaggiari GM, et al. Mesenchymal stromal cells induce peculiar alternatively activated macrophages capable of dampening both innate and adaptive immune responses. Stem Cells. 2016 Jul;34(7):1909–1921. doi: 10.1002/stem.2369
   PubMed Web of Science ®Google Scholar
• Davies LC, Heldring N, Kadri N, et al. Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression. Stem Cells. 2017 Mar;35(3):766–776. doi: 10.1002/stem.2509
   PubMed Web of Science ®Google Scholar
• Ala M, Eftekhar SP. The footprint of kynurenine pathway in cardiovascular diseases. Int J Tryptophan Res. 2022;15:11786469221096643. doi: 10.1177/11786469221096643
   Web of Science ®Google Scholar
• Laing AG, Fanelli G, Ramirez-Valdez A, et al. Mesenchymal stem cells inhibit T-cell function through conserved induction of cellular stress. Plos One. 2019;14(3):e0213170. doi: 10.1371/journal.pone.0213170
   PubMed Web of Science ®Google Scholar
• Ringdén O, Uzunel M, Rasmusson I, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation. 2006 May 27;81(10):1390–1397.
   PubMed Web of Science ®Google Scholar
• Weiß E, Ramos GC, Delgobo M. Myocardial-treg crosstalk: how to tame a wolf. Front Immunol. 2022;13:914033. doi: 10.3389/fimmu.2022.914033
   PubMed Web of Science ®Google Scholar
• Sun K, Li Y and Jin J. (2021). A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair. Sig Transduct Target Ther, 6(1). doi: 10.1038/s41392-020-00455-6
   Web of Science ®Google Scholar
• Spaggiari GM, Capobianco A, Abdelrazik H, et al. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood. 2008 Feb 1;111(3):1327–1333.
   PubMed Web of Science ®Google Scholar
• Sun SJ, Lai WH, Jiang Y, et al. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction. Theranostics. 2021;11(4):1641–1654. doi: 10.7150/thno.46119
   PubMed Web of Science ®Google Scholar
• Dai Z, Aoki T, Fukumoto Y, et al. Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure. J Cardiol. 2012 Nov;60(5):416–421. doi: 10.1016/j.jjcc.2012.06.009
   PubMed Web of Science ®Google Scholar
• Mills JS, Rao SV. REPAIR-AMI: stem cells for acute myocardial infarction. Future Cardiol. 2007 Mar;3(2):137–140. doi: 10.2217/14796678.3.2.137
   PubMedGoogle Scholar
• Cochain C, Channon KM, Silvestre JS. Angiogenesis in the infarcted myocardium. Antioxid Redox Signal. 2013 Mar 20;18(9):1100–1113.
   PubMed Web of Science ®Google Scholar
• Tang J, Wang J, Yang J, et al. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats. Eur J Cardiothorac Surg. 2009 Oct;36(4):644–650. doi: 10.1016/j.ejcts.2009.04.052
   PubMed Web of Science ®Google Scholar
• Hutchings G, Janowicz K, Moncrieff L, et al. The proliferation and differentiation of adipose-derived stem cells in neovascularization and angiogenesis. Int J Mol Sci. 2020 May 27;21(11):3790.
   PubMed Web of Science ®Google Scholar
• Wang L, Deng J, Tian W, et al. Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. Am J Physiol Heart Circ Physiol. 2009;297(3):H1020–H1031. doi: 10.1152/ajpheart.01082.2008
   PubMed Web of Science ®Google Scholar
• Valina C, Pinkernell K, Song YH, et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J. 2007 Nov;28(21):2667–2677. doi: 10.1093/eurheartj/ehm426
   PubMed Web of Science ®Google Scholar
• Houtgraaf JH, WKd D, BMv D, et al. First experience in humans using adipose tissue–derived regenerative cells in the treatment of patients with ST-Segment elevation myocardial infarction. J Am Coll Cardiol. 2012;59(5):539–540. doi: 10.1016/j.jacc.2011.09.065
   PubMed Web of Science ®Google Scholar
• Gupta S, Sharma A, S A, et al. Mesenchymal stem cells for cardiac regeneration: from differentiation to cell delivery. Stem Cell Rev Rep. 2021 Oct;17(5):1666–1694. doi: 10.1007/s12015-021-10168-0
   PubMed Web of Science ®Google Scholar
• Oskowitz A, McFerrin H, Gutschow M, et al. Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res. 2011 May;6(3):215–225. doi: 10.1016/j.scr.2011.01.004
   PubMed Web of Science ®Google Scholar
• Premer C, Wanschel A, Porras V, et al. Mesenchymal stem cell secretion of SDF-1α modulates endothelial function in dilated cardiomyopathy. Front Physiol. 2019;10:1182. doi: 10.3389/fphys.2019.01182
   PubMed Web of Science ®Google Scholar
• Kwon HM, Hur S-M, Park K-Y, et al. Multiple paracrine factors secreted by mesenchymal stem cells contribute to angiogenesis. Vascul Pharmacol. 2014 Oct 01;63(1):19–28.
   PubMed Web of Science ®Google Scholar
• Gerber HP, McMurtrey A, Kowalski J, et al. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3’-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem. 1998 Nov 13;273(46):30336–30343.
   PubMed Web of Science ®Google Scholar
• Meadows KN, Bryant P, Pumiglia K. Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J Biol Chem. 2001 Dec 28;276(52):49289–49298.
   PubMed Web of Science ®Google Scholar
• Liang X, Ding Y, Zhang Y, et al. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant. 2014;23(9):1045–1059. doi: 10.3727/096368913X667709
   PubMed Web of Science ®Google Scholar
• Rufaihah AJ, Huang NF, Jamé S, et al. Endothelial cells derived from human iPSCS increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):e72–9. doi: 10.1161/ATVBAHA.111.230938
   PubMed Web of Science ®Google Scholar
• Assis-Ribas T, Forni MF, Winnischofer SMB, et al. Extracellular matrix dynamics during mesenchymal stem cells differentiation. Dev Biol. 2018 May 15;437(2):63–74.
   PubMed Web of Science ®Google Scholar
• Kachgal S, Putnam AJ. Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms. Angiogenesis. 2011 Mar;14(1):47–59. doi: 10.1007/s10456-010-9194-9
   PubMed Web of Science ®Google Scholar
• Mauritz C, Martens A, Rojas SV, et al. Induced pluripotent stem cell (Ipsc)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J. 2011;32(21):2634–2641. doi: 10.1093/eurheartj/ehr166
   PubMed Web of Science ®Google Scholar
• Zhang H, Yamaguchi T, Kokubu Y, et al. Transient ETV2 expression promotes the generation of mature endothelial cells from human pluripotent stem cells. Biol Pharm Bull. 2022;45(4):483–490. doi: 10.1248/bpb.b21-00929
   PubMed Web of Science ®Google Scholar
• Kurian GA, Rajagopal R, Vedantham S, et al. The role of oxidative stress in myocardial ischemia and reperfusion injury and remodeling: revisited. Oxid Med Cell Longev. 2016;2016:1656450. doi: 10.1155/2016/1656450
   PubMed Web of Science ®Google Scholar
• Lodrini AM, Goumans M-J. Cardiomyocytes cellular phenotypes after myocardial infarction [review]. Front Cardiovasc Med. 2021 Nov 08;2021:8. doi: 10.3389/fcvm.2021.750510.
   Google Scholar
• Walkowski B, Kleibert M, Majka M, et al. Insight into the role of the PI3K/Akt pathway in ischemic injury and post-infarct left ventricular remodeling in normal and diabetic heart. Cells. 2022 May 5;11(9):1553.
   PubMed Web of Science ®Google Scholar
• Yan B, Singla DK. Transplanted induced pluripotent stem cells mitigate oxidative stress and improve cardiac function through the Akt cell survival pathway in diabetic cardiomyopathy. Mol Pharm. 2013 Sep 3;10(9):3425–3432.
   PubMedGoogle Scholar
• Chen B, Chen X, Liu C, et al. Co-expression of Akt1 and Wnt11 promotes the proliferation and cardiac differentiation of mesenchymal stem cells and attenuates hypoxia/reoxygenation-induced cardiomyocyte apoptosis. Biomed Pharmacother. 2018 Dec;108:508–514.
   PubMed Web of Science ®Google Scholar
• Karetnikova V N, Kashtalap V V, Kosareva S N and Barbarash O L. (2017). Myocardial fibrosis: Current aspects of the problem. Terapevticheskii arkhiv, 89(1), 88–93. doi: 10.17116/terarkh201789188-93
   PubMed Web of Science ®Google Scholar
• Arai AE. Healing after myocardial infarction: a loosely defined process. JACC Cardiovasc Imaging. 2015 Jun;8(6):680–683. doi: 10.1016/j.jcmg.2015.02.012
   PubMed Web of Science ®Google Scholar
• Karantalis V, DiFede DL, Gerstenblith G, et al. Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial. Circ Res. 2014 Apr 11;114(8):1302–1310.
   PubMed Web of Science ®Google Scholar
• Hassink RJ, Pasumarthi KB, Nakajima H, et al. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc Res. 2008 Apr 1;78(1):18–25.
   PubMed Web of Science ®Google Scholar
• Schang LM. The cell cycle, cyclin-dependent kinases, and viral infections: new horizons and unexpected connections. Prog Cell Cycle Res. 2003;5:103–124.
   PubMedGoogle Scholar
• Zhu W, Zhao M, Mattapally S, et al. CCND2 overexpression enhances the regenerative potency of human induced pluripotent stem cell-derived cardiomyocytes: remuscularization of injured ventricle. Circ Res. 2018 Jan 5;122(1):88–96. doi: 10.1161/CIRCRESAHA.117.311504.
   PubMed Web of Science ®Google Scholar
• Zhao M, Nakada Y, Wei Y, et al. Cyclin D2 Overexpression enhances the efficacy of human induced pluripotent stem cell-derived cardiomyocytes for myocardial repair in a swine model of myocardial infarction. Circulation. 2021 Jul 20;144(3):210–228.
   PubMed Web of Science ®Google Scholar
• Kanelidis AJ, Premer C, Lopez J, et al. Route of delivery modulates the efficacy of mesenchymal stem cell therapy for myocardial infarction: a meta-analysis of preclinical studies and clinical trials. Circ Res. 2017 Mar 31;120(7):1139–1150.
   PubMed Web of Science ®Google Scholar
• Fakoya AO. New delivery systems of stem cells for vascular regeneration in ischemia. Front Cardiovasc Med. 2017;4:7. doi: 10.3389/fcvm.2017.00007
   PubMed Web of Science ®Google Scholar
• Bagno LL, Salerno AG, Balkan W, et al. Mechanism of Action of Mesenchymal Stem Cells (MSCs): impact of delivery method. Expert Opin Biol Ther. 2022 Apr;22(4):449–463. doi: 10.1080/14712598.2022.2016695
   PubMed Web of Science ®Google Scholar
• Masterson CH, Tabuchi A, Hogan G, et al. Intra-vital imaging of mesenchymal stromal cell kinetics in the pulmonary vasculature during infection. Sci Rep. 2021 Mar 04;11(1):5265.
   PubMed Web of Science ®Google Scholar
• Fischer UM, Harting MT, Jimenez F. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009;18(5):683–692. doi: 10.1089/scd.2008.0253
   PubMed Web of Science ®Google Scholar
• Schrepfer S, Deuse T, Reichenspurner H, et al. Stem cell transplantation: the lung barrier. Transplant Proc. 2007 Mar;39(2):573–576. doi: 10.1016/j.transproceed.2006.12.019
   PubMed Web of Science ®Google Scholar
• De Becker A, Riet IV. Homing and migration of mesenchymal stromal cells: how to improve the efficacy of cell therapy? World J Stem Cells. 2016 Mar 26;8(3):73–87.
   PubMed Web of Science ®Google Scholar
• Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell. 2009 Mar 6;4(3):206–216.
   PubMed Web of Science ®Google Scholar
• Lee RH, Pulin AA, Seo MJ, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009 Jul 2;5(1):54–63.
   PubMed Web of Science ®Google Scholar
• Zhang J, Bolli R, Garry DJ, et al. Basic and translational research in cardiac repair and regeneration: JACC state-of-the-art review. J Am Coll Cardiol. 2021 Nov 23;78(21):2092–2105.
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Blankenship JC, et al. ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation. 2011 Dec 6;124(23):e574–651.
   PubMed Web of Science ®Google Scholar
• de Jong R, Houtgraaf JH, Samiei S, et al. Intracoronary stem cell infusion after acute myocardial infarction: a meta-analysis and update on clinical trials. Circ Cardiovasc Interv. 2014 Apr;7(2):156–167. doi: 10.1161/CIRCINTERVENTIONS.113.001009
   PubMed Web of Science ®Google Scholar
• Watanabe M, Yavagal DR. Intra-arterial delivery of mesenchymal stem cells. Brain Circ. 2016 Jul;2(3):114–117. doi: 10.4103/2394-8108.192522
   PubMedGoogle Scholar
• Keith MCL, Tokita Y, Tang X-L, et al. Effect of the stop-flow technique on cardiac retention of c-kit positive human cardiac stem cells after intracoronary infusion in a porcine model of chronic ischemic cardiomyopathy. Basic Res Cardiol. 2015 Jul 07;110(5):46.
   Web of Science ®Google Scholar
• Premaratne GU, Tambara K, Fujita M, et al. Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction. Circ J. 2006 Sep;70(9):1184–1189. doi: 10.1253/circj.70.1184
   PubMed Web of Science ®Google Scholar
• Yigman Z, Ozdemir ED, Turan NN, et al. Umbilical cord mesenchymal stromal cells engraft and transdifferentiate into cardiomyocyte-like cells following acute myocardial ischemia⋆. Acta Histochem. 2020 Sep;122(6):151578. doi: 10.1016/j.acthis.2020.151578
   PubMed Web of Science ®Google Scholar
• Bagno L, Hatzistergos KE, Balkan W, et al. Mesenchymal stem cell-based therapy for cardiovascular disease: progress and challenges. Mol Ther. 2018 Jul 5;26(7):1610–1623.
   PubMed Web of Science ®Google Scholar
• Wysoczynski M, Khan A, Bolli R. New paradigms in cell therapy: repeated dosing, intravenous delivery, immunomodulatory actions, and new cell types. Circ Res. 2018 Jul 6;123(2):138–158.
   PubMed Web of Science ®Google Scholar
• Ravichandran R, Sridhar R, Venugopal JR, et al. Gold nanoparticle loaded hybrid nanofibers for cardiogenic differentiation of stem cells for infarcted myocardium regeneration. Macromol biosci. 2014;14(4):515–525. doi: 10.1002/mabi.201300407
   PubMed Web of Science ®Google Scholar
• Pala R, Anju VT, Dyavaiah M, et al. Nanoparticle-mediated drug delivery for the treatment of cardiovascular diseases. Int J Nanomedicine. 2020;15:3741–3769. doi: 10.2147/IJN.S250872
   PubMed Web of Science ®Google Scholar
• Yang H, Qin X, Wang H, et al. An in vivo miRNA delivery system for restoring infarcted myocardium. ACS Nano. 2019 Sep 24;13(9):9880–9894. doi: 10.1021/acsnano.9b03343.
   PubMed Web of Science ®Google Scholar
• Traverse JH, Henry TD, Pepine CJ, et al. TIME trial: effect of timing of stem cell delivery following ST-elevation myocardial infarction on the recovery of global and regional left ventricular function: final 2-year analysis. Circ Res. 2018 Feb 2;122(3):479–488.
   PubMed Web of Science ®Google Scholar
• Dai B, Huang W, Xu M, et al. Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function. J Am Coll Cardiol. 2011 Nov 08;58(20):2118–2127.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Sun S-J, Zhen Z, et al. Myocardial repair of bioengineered cardiac patches with decellularized placental scaffold and human-induced pluripotent stem cells in a rat model of myocardial infarction. Stem Cell Res Ther. 2021 Jan 07;12(1):13.
   PubMed Web of Science ®Google Scholar
• Pharmicell Co. L. A randomized, open labeled, multicenter trial for safety and efficacy of intracoronary adult human mesenchymal stem cells acute myocardial infarction 2013. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT01652209
   Google Scholar
• Inc HM. MiSaver® stem cell treatment for heart attack (acute myocardial infarction) 2019. Available from: https://classic.clinicaltrials.gov/ct2/show/record/NCT04050163
   Google Scholar
• Technology SLS. UC-MSC transplantation for left ventricular dysfunction after AMI 2023. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT03902067
   Google Scholar
• Sciences SUo M. MSCs for prevention of MI-induced HF (PREVENT-TAHA) 2021. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT05043610
   Google Scholar
• CellProthera. EXCELLENT (EXpanded CELL ENdocardiac Transplantation) 2024. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT02669810
   Google Scholar
• Taljaard M, Ward MR, Kutryk MJB, et al. Rationale and design of enhanced angiogenic cell therapy in acute myocardial infarction (ENACT-AMI): The first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction. Am Heart J. 2010 Mar 01;159(3):354–360.
   PubMed Web of Science ®Google Scholar
• Fernández-Avilés F, Sanz-Ruiz R, Bogaert J, et al. Safety and efficacy of intracoronary infusion of allogeneic human cardiac stem cells in patients with ST-Segment elevation myocardial infarction and left ventricular dysfunction. Circ Res. 2018 Aug 17;123(5):579–589.
   PubMed Web of Science ®Google Scholar
• Collins FS, Mansoura MK. The human genome project. Revealing the shared inheritance of all humankind. Cancer. 2001 Jan 1;91(1 Suppl):221–225.
   PubMed Web of Science ®Google Scholar
• Litman T. Personalized medicine—concepts, technologies, and applications in inflammatory skin diseases. APMIS. 2019;127(5):386–424. doi: 10.1111/apm.12934
   PubMed Web of Science ®Google Scholar
• Lu YF, Goldstein DB, Angrist M, et al. Personalized medicine and human genetic diversity. Cold Spring Harb Perspect Med. 2014 Jul 24;4(9):a008581.
   PubMed Web of Science ®Google Scholar
• Katsnelson A. Momentum grows to make ‘personalized’ medicine more ‘precise’. Nat Med. 2013 Mar;19(3):249. doi: 10.1038/nm0313-249
   PubMed Web of Science ®Google Scholar
• Rieger AC, Myerburg RJ, Florea V, et al. Genetic determinants of responsiveness to mesenchymal stem cell injections in non-ischemic dilated cardiomyopathy. EBioMedicine. 2019 Oct;48:377–385.
   PubMed Web of Science ®Google Scholar
• Delewi R, Hirsch A, Tijssen JG, et al. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis. Eur Heart J. 2014 Apr;35(15):989–998. doi: 10.1093/eurheartj/eht372
   PubMed Web of Science ®Google Scholar
• Loffredo FS, Steinhauser ML, Gannon J, et al. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell. 2011 Apr 8;8(4):389–398.
   PubMed Web of Science ®Google Scholar
• Ye M, Ni Q, Qi H, et al. Exosomes derived from human induced pluripotent stem cells-endothelia cells promotes postnatal angiogenesis in mice bearing ischemic limbs. Int J Biol Sci. 2019;15(1):158–168. doi: 10.7150/ijbs.28392
   PubMed Web of Science ®Google Scholar
• Moghaddam AS, Afshari JT, Esmaeili SA, et al. Cardioprotective microRnas: Lessons from stem cell-derived exosomal microRnas to treat cardiovascular disease. Atherosclerosis. 2019 Jun;285:1–9.
   PubMed Web of Science ®Google Scholar
• Carotenuto F, Teodori L, Maccari AM, et al. Turning regenerative technologies into treatment to repair myocardial injuries. J Cell Mol Med. 2020;24(5):2704–2716. doi: 10.1111/jcmm.14630
   PubMed Web of Science ®Google Scholar
• Lai CP, Kim EY, Badr CE, et al. Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters. Nat Commun. 2015 May 13;6(1):7029.
   PubMed Web of Science ®Google Scholar
• Bradley JA, Bolton EM, Pedersen RA. Stem cell medicine encounters the immune system. Nat Rev Immunol. 2002 Nov;2(11):859–871. doi: 10.1038/nri934
   PubMed Web of Science ®Google Scholar
• Lai RC, Arslan F, Lee MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010 May;4(3):214–222. doi: 10.1016/j.scr.2009.12.003
   PubMed Web of Science ®Google Scholar
• Xu MY, Ye ZS, Song XT, et al. Differences in the cargos and functions of exosomes derived from six cardiac cell types: a systematic review. Stem Cell Res Ther. 2019 Jun 27;10(1):194.
   PubMed Web of Science ®Google Scholar
• Khan M, Nickoloff E, Abramova T, et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ Res. 2015 Jun 19;117(1):52–64.
   PubMed Web of Science ®Google Scholar
• Adamiak M, Cheng G, Bobis-Wozowicz S, et al. Induced pluripotent stem cell (Ipsc)-derived extracellular vesicles are safer and more effective for cardiac repair than iPscs. Circ Res. 2018 Jan 19;122(2):296–309.
   PubMed Web of Science ®Google Scholar
• Maleki B, Alani B, Tamehri Zadeh SS, et al. MicroRNAs and exosomes: Cardiac stem cells in heart diseases. Pathol Res Pract. 2022 Jan 01;229:153701.
   PubMed Web of Science ®Google Scholar
• Çakmak HA, Demir M. MicroRNA and cardiovascular diseases. Balkan Med J. 2020 Feb 28;37(2):60–71.
   PubMed Web of Science ®Google Scholar
• Shao L, Zhang Y, Lan B, et al. MiRNA-Sequence indicates that mesenchymal stem cells and exosomes have similar mechanism to enhance cardiac repair. Biomed Res Int. 2017;2017:4150705. doi: 10.1155/2017/4150705
   PubMed Web of Science ®Google Scholar
• Torrini C, Cubero RJ, Dirkx E, et al. Common regulatory pathways mediate activity of MicroRNAs inducing cardiomyocyte proliferation. Cell Rep. 2019 May 28;27(9):2759–2771.e5. doi: 10.1016/j.celrep.2019.05.005.
   PubMed Web of Science ®Google Scholar
• Tian Y, Liu Y, Wang T, et al. A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice. Sci Transl Med. 2015 Mar 18;7(279):279ra38.
   PubMed Web of Science ®Google Scholar
• Sun X, Dai G, Yu L, et al. MiR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2. Sci Rep. 2018 Jan 12;8(1):606.
   PubMedGoogle Scholar
• Wen SY, Lin Y, Yu YQ, et al. MiR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer. Oncogene. 2015 Feb 5;34(6):717–725.
   PubMed Web of Science ®Google Scholar
• Mayourian J, Ceholski DK, Gorski PA, et al. Exosomal microRNA-21-5p mediates mesenchymal stem cell paracrine effects on human cardiac tissue contractility. Circ Res. 2018 Mar 30;122(7):933–944.
   PubMed Web of Science ®Google Scholar
• Yu B, Kim HW, Gong M, et al. Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRnas for cardioprotection. Int J Cardiol. 2015 Mar 1;182:349–360.
   PubMed Web of Science ®Google Scholar
• Liu L, Jin X, Hu CF, et al. Exosomes derived from mesenchymal stem cells rescue myocardial ischaemia/reperfusion injury by inducing cardiomyocyte autophagy via AMPK and akt pathways. Cell Physiol Biochem. 2017;43(1):52–68. doi: 10.1159/000480317
   PubMedGoogle Scholar
• Dougherty JA, Kumar N, Noor M, et al. Extracellular vesicles released by human induced-pluripotent stem cell-derived cardiomyocytes promote angiogenesis. Front Physiol. 2018;9:1794. doi: 10.3389/fphys.2018.01794
   PubMed Web of Science ®Google Scholar